ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Chicago, IL, USA:

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor...

Enrolling
Pancreatic Cancer
Device: Directional Brachytherapy Source Implant

Phase 1, Phase 2

CivaTech Oncology

Chicago, Illinois, United States and 4 other locations

Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...

Enrolling
Stage III Pancreatic Cancer
Drug: Modified FOLFIRINOX Regimen
Device: NanoKnife System

Phase 3

AngioDynamics
AngioDynamics

Arlington Heights, Illinois, United States and 5 other locations

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Other: Placebo

Phase 2

Walid Shaib, MD

Munster, Indiana, United States and 7 other locations

Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 2

Astellas
Astellas

Chicago, Illinois, United States and 135 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Chicago, Illinois, United States and 22 other locations

in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...

Enrolling
Metastatic Cancer
Neoplasms Pancreatic
Drug: avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

Phase 1, Phase 2

Verastem

Chicago, Illinois, United States and 11 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2

Agenus
Agenus

Arlington Heights, Illinois, United States and 35 other locations

A Phase Ib/II, open-label, multicenter, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor...

Active, not recruiting
Pancreatic Adenocarcinoma
Drug: Gemcitabine
Drug: Bevacizumab

Phase 1, Phase 2

Roche
Roche

Chicago, Illinois, United States and 26 other locations

to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...

Enrolling
Non-small Cell Lung Cancer
Colorectal Neoplasms
Drug: PF-08046049

Phase 1

Seagen
Seagen

Chicago, Illinois, United States and 21 other locations

stomach cancer, gastroesophageal junction cancer, (GEJ cancer) or pancreatic cancer. GEJ is where the t...

Enrolling
Pancreatic Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Drug: ASP2138
Drug: Irinotecan

Phase 1

Astellas
Astellas

Chicago, Illinois, United States and 36 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems